查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1766193

伤口治疗设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Wound Therapy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 90 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球伤口治疗设备市场规模达35亿美元，预计2034年将以4.5%的复合年增长率成长，达到54亿美元。慢性伤口病例（包括糖尿病足溃疡、压疮和下肢静脉溃疡）的增加是市场扩张的主要驱动力之一。这些类型的伤口通常需要更长时间才能癒合，并且需要专门的护理，这为先进的伤口治疗设备带来了巨大的发展机会。糖尿病、肥胖症和血管疾病等疾病的日益流行，也加剧了对负压伤口治疗 (NPWT) 和减压系统等先进技术的需求，这些技术有助于伤口癒合并减少併发症。

伤口治疗设备市场 - IMG1

此外，由于皮肤弹性下降、血液循环减慢以及其他与年龄相关的健康状况，全球老化人口面临着与伤口癒合相关的日益严峻的挑战。伤口治疗设备市场是更广泛的医疗器材产业的一部分，专注于开发、生产和分销用于辅助治疗和管理急性和慢性伤口（包括手术伤口、烧伤和创伤）的设备。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 35亿美元
预测值 54亿美元
复合年增长率 4.5%

2024年，负压伤口治疗 (NPWT) 领域占据市场主导地位，占据36.2%的市场。此疗法对治疗慢性伤口尤其有效，尤其是由糖尿病、肥胖和血管疾病等疾病引起的伤口。 NPWT 通过去除多余液体、减少肿胀和改善受影响组织的血流来加速癒合过程，使其在处理复杂伤口方面尤为重要。其在术后伤口护理中的有效性也促使其应用日益广泛，因为它有助于降低感染风险并促进手术伤口更快癒合。随着慢性疾病的持续增长，对 NPWT 的需求将持续增长，使其成为伤口治疗设备市场中的关键细分领域。

2024年，医院细分市场占据54.2%的市场。医院进行各种外科手术，包括骨科、心血管和一般外科手术，每种手术都可能导致需要高阶管理的伤口。伤口治疗设备，尤其是NPWT系统和专用敷料，在这些情况下至关重要，可预防感染、延迟癒合和伤口裂开等併发症。全球范围内手术数量的不断增长，以及对有效伤口护理的需求，推动了这些设备的需求，从而改善患者预后并缩短康復时间。医院还可以获得专业资源，例如伤口护理团队和先进的医疗设备，这进一步支持了这些先进设备的使用。

预计到2034年，美国伤口治疗设备市场规模将达21亿美元。这一增长主要源于糖尿病和心血管疾病等慢性疾病的高发生率，这些疾病导致伤口无法癒合的情况日益增加。对先进伤口护理技术（例如非侵入性通气治疗 (NPWT)、氧气治疗设备和伤口监测感测器）的需求正在增长，尤其是在医院和专科护理中心。美国医疗保健基础设施完善，拥有广泛的医护人员、专科医生网路以及先进的医疗技术，促进了这些设备的普及，从而有助于改善伤口癒合效果并提升患者的整体护理水平。

全球伤口治疗设备市场的一些领先公司包括 3M、B. Braun、Cardinal Health、Medtronic、Medela、Integra LifeSciences、Coloplast、Smith & Nephew、Lohmann & Rauscher、Molnlycke Health Care、Paul Hartmann、DeRoyal Industries、MiMedx、Organogenic 和 Cardinal Health。为了巩固其在伤口治疗设备市场的地位，各公司都优先考虑产品创新，专注于开发先进且更有效的设备，例如改进的 NPWT 系统和多功能伤口护理解决方案。

与医院、门诊中心和医疗保健提供者建立策略合作伙伴关係，对于企业确保其设备覆盖更广泛的市场并获得更广泛的应用至关重要。企业也正在投资为医疗保健专业人员提供全面的培训项目，以确保其产品的正确应用和整合。此外，企业正在透过引入生物活性伤口敷料和智慧伤口监测系统等新技术来扩展其产品组合，以增强整体伤口癒合过程。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
    • 供应商格局
    • 每个阶段的增值
    • 影响价值链的因素
  • 产业衝击力
    • 成长动力
      • 慢性伤口盛行率上升
      • 人口老化日益加剧
      • 伤口护理技术的进步
      • 外科手术和创伤病例增加
    • 产业陷阱与挑战
      • 先进伤口治疗设备成本高昂
      • 发展中国家的认识与采用有限
    • 市场机会
  • 成长潜力分析
  • 监管格局
  • 技术和创新格局
    • 当前的技术趋势
    • 新兴技术
  • 价格趋势
    • 按地区
    • 按产品
  • 报销场景
    • 报销政策对市场成长的影响
  • 未来市场趋势
  • 消费者行为分析
  • 专利分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 竞争市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係和合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：依产品类型，2021 年至 2034 年

  • 主要趋势
  • 负压伤口治疗
  • 高压氧治疗
  • 电刺激装置
  • 压力释放装置
  • 其他产品类型

第六章：市场估计与预测：按伤口类型，2021 年至 2034 年

  • 主要趋势
  • 慢性伤口
  • 急性伤口

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 专科诊所
  • 其他最终用途

第八章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • B. Braun
  • Cardinal Health
  • Coloplast
  • ConvaTec
  • DeRoyal Industries
  • Integra LifeSciences
  • Lohmann & Rauscher
  • Medela
  • Medtronic
  • MiMedx
  • Molnlycke Health Care
  • Organogenesis
  • Paul Hartmann
  • Smith & Nephew
  • 3M
简介目录
Product Code: 14049

The Global Wound Therapy Devices Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 4.5% to reach USD 5.4 billion by 2034. The rise in chronic wound cases, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is one of the primary drivers of market expansion. These types of wounds typically take longer to heal and require specialized care, which opens significant opportunities for advanced wound therapy devices. The growing prevalence of conditions like diabetes, obesity, and vascular diseases has escalated the need for advanced technologies like negative pressure wound therapy (NPWT) and pressure relief systems that aid in wound healing and reduce complications.

Wound Therapy Devices Market - IMG1

Additionally, the aging global population faces increased challenges related to wound healing due to reduced skin elasticity, diminished circulation, and other age-related health conditions. The market for wound therapy devices is part of the broader medical device industry, focusing on the development, production, and distribution of devices designed to aid in the treatment and management of both acute and chronic wounds, including surgical wounds, burns, and traumatic injuries.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.5 Billion
Forecast Value$5.4 Billion
CAGR4.5%

The negative pressure wound therapy (NPWT) segment led the market in 2024 with a substantial share of 36.2%. This therapy is particularly effective in treating chronic wounds, especially those caused by conditions such as diabetes, obesity, and vascular diseases. NPWT accelerates the healing process by removing excess fluids, reducing swelling, and improving blood flow to the affected tissue, making it particularly valuable for managing complex wounds. Its effectiveness in post-surgical wound care has also contributed to its growing use, as it helps to reduce the risk of infection and promotes faster healing of surgical wounds. As chronic diseases continue to rise, the demand for NPWT will continue to expand, making it a key segment within the wound therapy devices market.

The hospitals segment held a 54.2% share in 2024. Hospitals perform a wide range of surgical procedures, including orthopedic, cardiovascular, and general surgeries, each of which can result in wounds requiring advanced management. Wound therapy devices, particularly NPWT systems and specialized dressings, are critical in these settings to prevent complications like infections, delayed healing, and dehiscence. The demand for these devices is driven by the increasing number of surgeries being performed worldwide and the need for effective wound care to improve patient outcomes and reduce recovery times. Hospitals also have access to specialized resources, such as wound care teams and advanced medical equipment, which further support the use of these sophisticated devices.

U.S. Wound Therapy Devices Market is expected to reach USD 2.1 billion by 2034. This growth is driven by the high incidence of chronic conditions like diabetes and cardiovascular diseases, which lead to a growing number of non-healing wounds. The demand for advanced wound care technologies such as NPWT, oxygen therapy devices, and wound monitoring sensors is increasing, particularly in hospitals and specialized care centers. The U.S. healthcare infrastructure, with its extensive network of healthcare practitioners, specialists, and access to advanced medical technologies, facilitates the adoption of these devices, contributing to improved wound healing outcomes and better overall patient care.

Some of the leading companies operating in the Global Wound Therapy Devices Market include 3M, B. Braun, Cardinal Health, Medtronic, Medela, Integra LifeSciences, Coloplast, Smith & Nephew, Lohmann & Rauscher, Molnlycke Health Care, Paul Hartmann, DeRoyal Industries, MiMedx, Organogenesis, and Cardinal Health. To solidify their position in the wound therapy devices market, companies are prioritizing product innovation, focusing on developing advanced and more effective devices such as improved NPWT systems and multifunctional wound care solutions.

Strategic partnerships with hospitals, outpatient centers, and healthcare providers are essential for companies to ensure their devices reach broader markets and gain wider adoption. Companies are also investing in comprehensive training programs for healthcare professionals to ensure proper application and integration of their products. Additionally, businesses are expanding their portfolios by introducing new technologies like bioactive wound dressings and smart wound monitoring systems to enhance the overall wound healing process.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Application
    • 2.2.4 End Use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic wounds
      • 3.2.1.2 Growing aging population
      • 3.2.1.3 Advancements in wound care technologies
      • 3.2.1.4 Increased surgical procedures and trauma cases
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced wound therapy devices
      • 3.2.2.2 Limited awareness and adoption in developing countries
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Price trends
    • 3.6.1 By region
    • 3.6.2 By product
  • 3.7 Reimbursement scenario
    • 3.7.1 Impact of reimbursement policies on market growth
  • 3.8 Future market trends
  • 3.9 Consumer behaviour analysis
  • 3.10 Patent analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Competitive market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Negative pressure wound therapy
  • 5.3 Hyperbaric oxygen therapy
  • 5.4 Electric stimulation devices
  • 5.5 Pressure relief devices
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Wound Type, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Chronic wounds
  • 6.3 Acute wounds

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Specialty clinics
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Mexico
    • 8.5.2 Brazil
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 B. Braun
  • 9.2 Cardinal Health
  • 9.3 Coloplast
  • 9.4 ConvaTec
  • 9.5 DeRoyal Industries
  • 9.6 Integra LifeSciences
  • 9.7 Lohmann & Rauscher
  • 9.8 Medela
  • 9.9 Medtronic
  • 9.10 MiMedx
  • 9.11 Molnlycke Health Care
  • 9.12 Organogenesis
  • 9.13 Paul Hartmann
  • 9.14 Smith & Nephew
  • 9.15 3M